ClinicalTrials.gg
CompletedNCT07757009FAMUpdated Aug 11, 2026

Perioperative Forced-Air Warming During Elective Cesarean Delivery Under Spinal Anesthesia

An interventional study of Forced-Air Warming in Perioperative Hypothermia and Maternal Hypothermia, sponsored by Hamad Medical Corporation. Completed at 1 site in Qatar. Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-11.

Sponsored by Hamad Medical Corporation · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Registered 3 years 2 months after the study started (first participant enrolled Jun 2023, registered Aug 2026).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

Intraoperative hypothermia is common during cesarean delivery under spinal anesthesia and contributes to maternal discomfort, shivering, and metabolic stress. Active warming systems such as forced-air warming are recommended in perioperative guidelines; however, their effectiveness in obstetric anesthesia remains variably documented.

This randomized controlled trial evaluated whether perioperative forced-air warming reduces maternal hypothermia and shivering during elective cesarean section under spinal anesthesia without adversely affecting neonatal outcomes.

Read the detailed description

Spinal anesthesia impairs thermoregulation by inhibiting vasoconstriction and redistributing core heat to peripheral compartments. As a result, parturients undergoing cesarean delivery are at increased risk of peri-operative hypothermia (\<36°C). Even mild hypothermia is associated with shivering, increased oxygen consumption, and maternal discomfort.

This prospective randomized controlled trial compared preoperative forced-air warming with standard thermal care in term parturients undergoing elective cesarean delivery under spinal anesthesia.

The study was conducted between June 2023 and December 2025. A total of 120 participants were enrolled and randomized equally into two groups. Maternal core temperature trends, incidence of hypothermia, shivering, thermal comfort, and neonatal outcomes were analyzed.

02

Conditions studied

  • Perioperative Hypothermia
  • Maternal Hypothermia

Browse trials for

Keywords

  • Cesarean Section
  • Elective Cesarean Delivery
  • Spinal Anesthesia
  • Maternal Hypothermia
  • Perioperative Hypothermi
  • Forced-Air Warming
  • Active Warming
  • Maternal Temperature
  • Shivering
  • Thermal Comfort
  • Obstetric Anesthesia
  • Neonatal Outcomes
03

In context

Hypothermia

450 studies on the registry are indexed under Hypothermia; 53 are open to participants now.

This study's enrollment of 120 is above the median of 76 across 329 interventional studies indexed under Hypothermia.

Browse Hypothermia studies →

Lead sponsor

Hamad Medical Corporation is the lead sponsor of 139 studies on the registry; 27 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

    • Age ≥18 years

      • Term pregnancy (≥37 weeks' gestation)
      • Scheduled elective cesarean delivery
      • I-II
      • Undergoing spinal anesthesia
      • Provided written

Exclusion criteria

Exclusion Criteria:

    • Emergency cesarean section

      • Preoperative fever (>38°C) or hypothermia
      • Thyroid or significant metabolic disorders
      • Known intrauterine infection
      • to spinal anesthesia
      • Refusal to participate
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
120 participants (actual)

Study arms

  • Experimental
    Perioperative Forced-Air Warming

    Participants received perioperative forced-air warming during elective cesarean delivery under spinal anesthesia in addition to standard perioperative care.

    Device: Forced-Air Warming

  • No intervention
    Standard Care

    Participants received standard perioperative care without forced-air warming during elective cesarean delivery under spinal anesthesia.

Interventions

  • DeviceForced-Air Warming

    Perioperative forced-air warming was administered using a forced-air warming device during elective cesarean delivery under spinal anesthesia to maintain maternal normothermia.

06

What researchers measure

Primary outcomes

  1. Incidence of maternal hypothermia (<36°C)

    Maternal hypothermia is defined as a core body temperature \<36.0°C measured intraoperatively and in the immediate postoperative period.

    Time frame: From induction of spinal anesthesia until discharge from the post-anesthesia care unit (approximately 3 hours).

  2. Incidence of Maternal Hypothermia

    Maternal hypothermia is defined as a core body temperature of \<36.0°C measured intraoperatively and in the immediate postoperative period.

    Time frame: From induction of spinal anesthesia until discharge from the post-anesthesia care unit (approximately 3 hours).

Secondary outcomes

  1. Maternal Shivering Score

    Maternal shivering will be assessed using a four-point shivering scale ranging from 0 to 3: 0 = no shivering; 1 = intermittent, low-intensity shivering; 2 = moderate shivering; and 3 = continuous, intense shivering. Higher scores indicate greater severity of shivering.

    Time frame: This period extends from the preoperative phase through surgery and into the first hour in the post-anesthesia care unit (PACU).

Other outcomes

  1. Neonatal Temperature at Birth

    Neonatal axillary temperature measured immediately after delivery.

    Time frame: Immediately after birth

07

Study locations

1 site
  • Hamad Medical Corporation
    Al Rayyan, Baladiyat ad Dawhah 3050, Qatar
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jun 2023 to primary completion in Dec 2025, 30 months.

Of 137 interventional studies with no phase under Hypothermia, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 35. This study's 30 months is above that.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 2, 2026
First posted
Aug 11, 2026
StartActual
Jun 1, 2023
Primary completionActual
Dec 1, 2025
CompletionActual
Dec 31, 2025
Last update
Aug 11, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 11, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07757009
Responsible party
Dr. Eynas Omer Ibrahim Abdalla (Consultant Anesthesiology, Hamad Medical Corporation) — Principal investigator
First posted
Aug 11, 2026
Start date
Jun 1, 2023
Primary completion
Dec 1, 2025
Completion
Dec 31, 2025
Last update
Aug 11, 2026

Study contacts

Dr Eynas Omer Ibrahim Abdalla, Arab Board
principal investigator · Hamad Medical Corporation

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion